CG
NUTX

Caprock Group’s Nutex Health NUTX Stock Holding History

Caprock Group’s Portfolio NUTX Stock Details NUTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$370K Buy
+2,165
New +$274K 0.01% 960

Other funds holding NUTX

PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Winmill & Co Walpole, New Hampshire $452M AUM 56.84% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

Caprock Group's NUTX Position: Q2 2026 in Review

Caprock Group opened a new position in Nutex Health (NUTX) in Q2 2026: 2,165 shares worth $370K. The stake represents 0.01% of the portfolio and ranks #960 among its holdings.

154 funds tracked by Wall St. Rank hold NUTX as of Q2 2026.

  • Caprock Group held 2,165 shares of Nutex Health worth $370K as of Q2 2026.
  • Nutex Health was a new Caprock Group position in Q2 2026.
  • Nutex Health made up 0.01% of Caprock Group's portfolio in Q2 2026, its #960 holding.
  • 154 funds tracked by Wall St. Rank held Nutex Health as of Q2 2026.

Based on Caprock Group's 13F filing for Q2 2026, filed 27 Jul 2026.